NCT05300958 2025-07-22
Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer
Sun Yat-sen University
Phase 2 Terminated
Clinical Trials
8 trialsNCT03393741 2024-06-25
Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy
University of Wisconsin, Madison
Terminated
NCT00004935 2023-04-18
Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
Swiss Cancer Institute
Phase 3 Terminated
NCT03386162 2022-11-28
SAFIR-PI3K
UNICANCER
Phase 2 Terminated
NCT02000596 2022-05-27
1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.
University of Maryland, Baltimore
Phase 2 Terminated
NCT03055312 2021-01-28
SYSUCC-007
Sun Yat-sen University
Phase 3 Terminated
NCT01368263 2015-04-03
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
Washington University School of Medicine
Phase 2 Terminated
NCT01928615 2014-09-29
LISAH
Hoffmann-La Roche
Phase 2 Terminated